Effects of aspirin on risks of vascular events and cancer according to bodyweight and dose: analysis of individual patient data from randomised trials.

导出 OA

翻译打印收藏纠错

作者： Peter M,Rothwell ^[1] ; Nancy R,Cook ^[2] ; J Michael,Gaziano ^[3] ; Jacqueline F,Price ^[4] ; Jill F F,Belch ^[5] ; Maria Carla,Roncaglioni ^[6] ; Takeshi,Morimoto ^[7] ; Ziyah,Mehta ^[8]

作者单位： Centre for Prevention of Stroke and Dementia, Nuffield Department of Clinical Neuroscience, University of Oxford, Oxford, UK. Electronic address: peter.rothwell@clneuro.ox.ac.uk. ^[1] Division of Preventive Medicine, Department of Medicine, Brigham and Women's Hospital, Boston, MA, USA; Harvard Medical School, Boston, MA, USA. ^[2] Harvard Medical School, Boston, MA, USA. ^[3] Usher Institute of Population Health Sciences and Informatics, University of Edinburgh, Edinburgh, UK. ^[4] Institute of Cardiovascular Research, Vascular and Inflammatory Diseases Research Unit, University Division of Medicine and Therapeutics, Ninewells Hospital and Medical School, Dundee, UK. ^[5] Istituto di Ricerche Farmacologiche Mario Negri, Milan, Italy. ^[6] Department of Clinical Epidemiology, Hyogo College of Medicine, Nishinomiya, Japan. ^[7] Centre for Prevention of Stroke and Dementia, Nuffield Department of Clinical Neuroscience, University of Oxford, Oxford, UK. ^[8]